MFDS Tightens ZLD Certification With KOLAS TOC Traceability

Effective September 1, 2026, South Korea’s MFDS will apply a revised certification requirement to ZLD wastewater treatment systems used in the pharmaceutical and biomanufacturing fields. The change matters because it adds a specific KOLAS-based TOC carbon-source isotope verification step to certification filings, directly affecting compliance preparation, type-testing timelines, and delivery planning for exporters and system suppliers working with TOC Removal modules, Heat Recovery units, and Liquid Purity monitoring subsystems.

What the revised certification rule confirms

According to the user-provided event summary, the Ministry of Food and Drug Safety (MFDS) issued the Detailed Rules for ZLD Protocols Certification (2026 Revision) on June 15, 2026. Under that revision, from September 1, 2026, all wastewater treatment systems applying for ZLD certification in South Korea’s pharmaceutical and biomanufacturing sectors must provide a TOC carbon-source isotope (δ13C) traceability verification report issued by a KOLAS-accredited laboratory.

The requirement applies to the ZLD systems covered in the filing, including TOC Removal core modules, Heat Recovery heat-exchange units, and Liquid Purity online monitoring subsystems. The report must demonstrate a TOC removal rate of at least 99.99% and show that there is no risk of secondary pollution.

The same event summary indicates that this requirement is expected to affect the type-testing cycle and cost structure of China’s Top 50 ZLD system exporters.

Where the practical pressure is likely to appear first

Export-oriented system suppliers face a new documentation threshold

From an industry perspective, exporters targeting the South Korean pharmaceutical and biomanufacturing market are likely to feel the impact first because the new filing condition is tied to certification eligibility rather than to a purely optional technical preference. What deserves closer attention is the need to align product files, testing arrangements, and certification schedules with a KOLAS-accredited laboratory report before submission.

For these companies, the most immediate business impact is likely to fall on type-testing sequencing, export project timing, and technical document readiness. The relevant compliance change is not only performance proof, but also the required form of proof.

Procurement and project owners may tighten bid and acceptance terms

Analysis shows that procurement teams and project owners involved in ZLD system sourcing for the affected sectors may need to pay closer attention to whether suppliers can provide the required δ13C traceability verification as part of the certification package. In practice, this can influence pre-bid qualification reviews, technical specification alignment, and acceptance planning for systems intended for the South Korean market.

Even where a supplier’s core treatment capability is not in question, procurement decisions may increasingly depend on whether the supporting verification documents are available in the required accreditation framework and whether delivery schedules account for the added certification step.

Testing and certification service providers become more central to delivery planning

Observably, the revision also raises the importance of testing and certification support providers because a KOLAS-accredited laboratory report is now part of the certification pathway described in the event summary. For companies already preparing market access or shipment plans, this means laboratory coordination may become a more visible factor in project scheduling, document completeness, and customer communication.

The practical point for service providers and their clients is that laboratory capacity, report timing, and technical traceability records may now have a more direct link to contract execution and compliance readiness.

What companies should review before the September effective date

Check whether existing certification files match the new evidence requirement

Analysis shows that companies with pending or planned ZLD certification submissions should review whether their current filing materials already include the form of TOC traceability evidence now required by MFDS. If not, the gap is not merely technical; it may affect whether an application package is considered complete under the revised process.

Reassess testing schedules and delivery commitments

What deserves closer attention is the interaction between the September 1, 2026 effective date and ongoing export or project delivery plans. Where contracts, production schedules, or customer commitments depend on certification progress, companies may need to revisit internal timelines to account for the additional verification step and the possibility of a longer type-testing cycle.

Review technical documents for covered subsystems

The event summary specifically mentions TOC Removal core modules, Heat Recovery units, and Liquid Purity online monitoring subsystems. Companies should therefore focus their document review on whether these subsystems are consistently reflected across technical files, testing materials, and certification submission packages.

Continue monitoring execution language and market feedback

Because the input does not provide fuller implementation details beyond the revised rule itself, it is more appropriate to treat the current development as a confirmed compliance change with execution details still worth tracking. Companies should keep watching for how certification language, customer requirements, tender documents, and practical review expectations evolve around the new verification requirement.

Why this reads as an execution signal, not just a policy update

Observably, this development is more than a general statement of environmental intent because it ties ZLD certification to a named verification pathway, a defined accreditation basis, and a measurable TOC removal threshold. That makes it more appropriate to understand the update as an execution-oriented compliance signal rather than as a broad policy direction without procedural consequences.

At the same time, analysis shows that the market still needs to observe how consistently the requirement is reflected in application review practice, procurement language, and supplier qualification expectations. The rule change itself is confirmed in the provided summary, but the pace and form of implementation across actual projects still deserve continued attention.

How the market may best interpret the change now

At this stage, the most balanced reading is that MFDS has introduced a more specific certification gate for ZLD systems entering the relevant South Korean pharmaceutical and biomanufacturing applications. The immediate significance lies in compliance preparation, testing coordination, and export execution rather than in any confirmed market outcome beyond those process effects already indicated in the input.

From an industry perspective, companies should not treat this only as a technical testing issue. It is also a documentation, scheduling, and market-access issue that may affect how suppliers prepare bids, plan certification, and manage customer delivery expectations after September 1, 2026.

Basis of this article and points still requiring verification

This article is generated based on the user-provided news title, event date, and event summary. For developments of this kind, relevant source types typically include official regulatory notices, releases from supervisory authorities, trade or customs authorities, industry association updates, standards documents, certification guidance, and reporting by authoritative industry media.

A specific official source link was not provided in the input, so the underlying notice and any later explanatory materials still require ongoing verification. What remains worth monitoring includes detailed implementation language, certification review practice, tender document changes, market feedback, and how affected companies adjust testing and compliance execution in response to the revised MFDS process.